Concepedia

Weng In Leong

WI

Statistics

Publications

1

Citations

20

H-Index

1

Active since

2019

Affiliations

Dynavax Technologies (United States)(Current)

Weng In Leong is an author at Dynavax Technologies (United States) specializing in t cell-based immunotherapy, innate immunity, and life sciences.

Publications per year

2019–2019

1

Publications

1

Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses

Weng In Leong, Rachel Y. Ames, Jessica M. Haverkamp et al. · Oncotarget · 2019 · 20 citations · Full text

, , +17

1–1 of 1